Paula M. Cannon

Overview

Best Publications

• A transient three-plasmid expression system for the production of high titer retroviral vectors

  Yuko Soneoka;Paula M. Cannon;Emma E. Ramsdale;Joanne C. Griffiths

  1053
  Citations

• Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo

  Nathalia Holt;Jianbin Wang;Kenneth Kim;Geoffrey Friedman

  824
  Citations

• International AIDS Society global scientific strategy: towards an HIV cure 2016

  Steven G Deeks;Sharon R Lewin;Anna Laura Ross;Jintanat Ananworanich

  473
  Citations

• AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges

  Matthew R. Gardner;Lisa M. Kattenhorn;Hema R. Kondur;Markus von Schaewen

  357
  Citations

• Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.

  Steven G. Deeks;Nancie Archin;Paula Cannon;Simon Collins

  354
  Citations

• Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors

  Jianbin Wang;Colin M Exline;Joshua J DeClercq;G Nicholas Llewellyn

  328
  Citations

• Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.

  Mei Chen;Noriyuki Kasahara;Douglas R Keene;Lawrence Chan

  291
  Citations

• Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency.

  Marella D Canny;Nathalie Moatti;Leo C K Wan;Leo C K Wan;Amélie Fradet-Turcotte;Amélie Fradet-Turcotte

  246
  Citations

• Genomic Editing of the HIV-1 Coreceptor CCR5 in Adult Hematopoietic Stem and Progenitor Cells Using Zinc Finger Nucleases

  Lijing Li;Ludmila Krymskaya;Jianbin Wang;Jill Henley

  214
  Citations

• HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment

  Heiko Hauser;Lisa A Lopez;Su Jung Yang;Jill E Oldenburg

  204
  Citations

• New World Clade B Arenaviruses Can Use Transferrin Receptor 1 (TfR1)-Dependent and -Independent Entry Pathways, and Glycoproteins from Human Pathogenic Strains Are Associated with the Use of TfR1

  Meg L. Flanagan;Jill Oldenburg;Therese Reignier;Nathalia Holt

  155
  Citations

• Sequences in the Cytoplasmic Tail of the Gibbon Ape Leukemia Virus Envelope Protein That Prevent Its Incorporation into Lentivirus Vectors

  Ilias Christodoulopoulos;Paula M. Cannon

  155
  Citations

• Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues.

  P M Cannon;W Wilson;E Byles;S M Kingsman

  148
  Citations

• Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.

  Lisa A. Lopez;Su Jung Yang;Heiko Hauser;Colin M. Exline

  143
  Citations

• Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein.

  M M Januszeski;P M Cannon;D Chen;Y Rozenberg

  132
  Citations

• Genome editing technologies: defining a path to clinic.

  Jacqueline Corrigan-Curay;Marina O'Reilly;Donald B Kohn;Paula M Cannon

  126
  Citations

• Delivery methods and compositions for nuclease-mediated genome engineering

  Paula M. Cannon;Colin Michael Exline;Michael C. Holmes

  122
  Citations

• Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17.

  Paula M. Cannon;Stephen Matthews;Nigel Clark;Elaine D. Byles

  121
  Citations

• Chemokine receptor 5 knockout strategies.

  Paula Cannon;Carl June

  121
  Citations

• Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells

  David L DiGiusto;Paula M Cannon;Michael C Holmes;Lijing Li

  115
  Citations